None listed
Conditions
Brief summary
Endoscopic ultrasound can obtain fluid using a technique known as fine needle aspiration (FNA). This involves a needle entering a pancreatic cyst and sucking fluid out. However, this test risks introducing gut bacteria into a normally sterile space. As such antibiotics may be effective to prevent infections. We aim to test whether Tazocin or Ciprofloxacin if penicillin allergy is present, prevents infections or is associated with increased harm.
Interventions
Patients having endoscopic ultrasound fine needle aspiration are at risk of iatrogenic infections due to the procedure. Currently there are no firm guidelines as to whether antibiotics are required or if they are, what antibiotics should be used. There have been no studies focusing on Tazocin (tazobactam, piperacillin) at the time of endoscopic ultrasound fine needle aspiration (EUS FNA). We will include all cases of EUS FNA requiring antibiotic prophylaxis and follow up patients following discharge home to determine whether they develop acute or chronic infections. Observational study will be conducted determining the rates of sepsis following EUS FNA (single periprocedural dose IV tazocin or ciprofloxacin) on telephone follow up 1 year post-procedure
Sponsors
Eligibility
Inclusion criteria
Age 16 - 90 Pancreatic cyst requiring fine needle aspiration Consenting to procedure
Exclusion criteria
Coagulopathy Not possible to safely perform EUS FNA eg cyst not well-positioned